TP53 and endometrial cancer: In addition, LINE-1-ORF1p expression positively correlated with P53 mutation, copy number Alteration (CNA), and DNA replication initiation protein complex, and the expression of LINE-1-ORF1p was on average approximately two-fold higher in p53 mutant endometrial cancers.